Trials / Recruiting
RecruitingNCT06840470
Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being completed to determine if 8 weeks of treatment with imiquimod can shrink sebaceous hyperplasia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Imiquimod 5% Topical Cream | Participants will apply this cream to one side of the face 3 times a week for up to 8 weeks. The cream will be applied before bedtime. The imiquimod should be washed off with mild soap and water after 6-10 hours. Participants will have baseline and follow-up visits that will include photographs of the lesions. |
Timeline
- Start date
- 2025-03-11
- Primary completion
- 2027-03-11
- Completion
- 2027-09-11
- First posted
- 2025-02-21
- Last updated
- 2025-04-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06840470. Inclusion in this directory is not an endorsement.